Visiox Pharma LLC, a US-based, privately funded biopharmaceutical company, announced on Wednesday that it has appointed Vicente Anido Jr., Ph.D. as its new strategic advisor.
Anido has previously served as chief executive officer at Aerie Pharmaceuticals and at ISTA Pharmaceuticals.
Anido said: "This is an exciting time in eye care to establish a new company that is following in the footsteps of a proven commercial platform. I am eager to help bring two novel drugs to the largest eye care markets inside a year while evaluating additional late-stage products to expand the Visiox pipeline."
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer